The U.S. health regulator s staff on Wednesday flagged concerns that data on Merck s chronic cough drug might not be enough to prove the treatment s meaningful benefit.
An artificial intelligence electrocardiography app cut catheterization lab activation times by 9 minutes in ST-elevation myocardial infarction patients.